BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35717430)

  • 1. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.
    Jain T; Sharma P; Giri B; Iyer S; Sethi V; Bava EP; Vaish U; Sahay P; Datta J; Reddy S; Bart Rose J; Khan A; Merchant N; Chari ST; Dudeja V
    HPB (Oxford); 2022 Oct; 24(10):1729-1737. PubMed ID: 35717430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
    Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
    Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
    Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
    ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency.
    Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J
    Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy in the Treatment of Exocrine Pancreatic Insufficiency.
    Barkin JA; Harb D; Kort J; Barkin JS
    Pancreas; 2024 Jan; 53(1):e16-e21. PubMed ID: 38039440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative management of pancreatic exocrine insufficiency-evidence-based proposal for a paradigm shift in pancreatic surgery.
    Stern L; Schuette M; Goetz MR; Nitschke C; Bardenhagen J; Scognamiglio P; Stüben BO; Calavrezos L; Amin T; Heumann A; Lohse AW; de Heer G; Izbicki JR; Uzunoglu FG
    HPB (Oxford); 2024 Jan; 26(1):117-124. PubMed ID: 37770362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes.
    Lewis DM; Shahid A
    J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis.
    Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D
    Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
    Roberts KJ; Schrem H; Hodson J; Angelico R; Dasari BVM; Coldham CA; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; Mirza DF
    HPB (Oxford); 2017 Oct; 19(10):859-867. PubMed ID: 28711377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
    Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
    BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.
    Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D
    Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
    Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L
    Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Population-level Prevalence of Exocrine Pancreas Insufficiency and the Subsequent Risk of Pancreatic Cancer.
    Babajide O; Desai A; Eruchalu C; Sedarous M; Adekunle D; Youssef M; Mahmud M; Okafor PN
    Pancreas; 2024 May; ():. PubMed ID: 38696443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exocrine pancreatic insufficiency following esophagectomy.
    Huddy JR; Macharg FM; Lawn AM; Preston SR
    Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Less common etiologies of exocrine pancreatic insufficiency.
    Singh VK; Haupt ME; Geller DE; Hall JA; Quintana Diez PM
    World J Gastroenterol; 2017 Oct; 23(39):7059-7076. PubMed ID: 29093615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study.
    Heinrich S; Besselink M; Moehler M; van Laethem JL; Ducreux M; Grimminger P; Mittler J; Lang H; Lutz MP; Lesurtel M;
    BMC Cancer; 2019 Jul; 19(1):675. PubMed ID: 31288786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
    Roberts KJ; Bannister CA; Schrem H
    Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.
    Dunleavy L; Al-Mukhtar A; Halliday V
    Clin Nutr ESPEN; 2018 Aug; 26():97-103. PubMed ID: 29908691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study].
    Bideeva TV; Maev IV; Kucheryavyy YA; Andreev DN; Shah YS; Lobanova EG; Zaborovskiy AV; Levchenko AI
    Ter Arkh; 2020 Jan; 92(1):30-35. PubMed ID: 32598660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
    Layer P; Kashirskaya N; Gubergrits N
    World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.